- Business Wire•11 hours ago
Gilead Sciences, Inc. announced today that its third quarter 2016 financial results will be released on Tuesday, November 1, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the third quarter 2016 and provide a general business update.
- Benzinga•13 hours ago
Jefferies maintained its Buy rating on Gilead Sciences, Inc. (NASDAQ: GILD ) saying that Wall Street underappreciated the impressiveness of last week's phase II 4997 data and shares don't reflect HIV stability ...
- Barrons.com•16 hours ago
Jefferies analyst Brian Abrahams and team contend that the Street missed the importance of last week's NASH data from Gilead Sciences (GILD). They explain why: Following discussions with a NASH key opinion ...
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Day's Range||73.91 - 74.68|
|52wk Range||72.21 - 110.77|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||6.53|
|Avg Vol (3m)||10,444,441|
|Dividend & Yield||1.88 (2.54%)|